Aclasta is a new standard of the efficiency of antiresorptive therapy: One-ayear infusion

Aclasta is a new standard of the efficiency of antiresorptive therapy: One-ayear infusion

Show other versions (1)

Bibliographic Details
Main Authors:	A M Mkrtumyan, L V Nedosugova, E V Biryukova, Ye V Biryukova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2008-03-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/147

Similar Items

Aclasta is a new standard of the efficiency of antiresorptive therapy: One-ayear infusion
by: A M Mkrtumyan, et al.
Published: (2008-03-01)

ORLISTAT IN COMBINATION THERAPY OF OBESITY AND TYPE 2 DIABETES
by: A. M. Mkrtumyan, et al.
Published: (2017-12-01)

Clinical efficacy and safety of linagliptin in patients with diabetes type 2
by: E. V. Biryukova, et al.
Published: (2016-12-01)

ROLE OF VITAMIN D IN THE EFFICIENCY OF ANTIRESORPTIVE THERAPY
by: N V Toroptsova
Published: (2009-06-01)

ROLE OF VITAMIN D IN THE EFFICIENCY OF ANTIRESORPTIVE THERAPY
by: N V Toroptsova
Published: (2009-06-01)

Osobennosti sakharnogo diabeta v pozhilom vozraste i printsipy terapii
by: Ashot Musaelovich Mkrtumyan, et al.
Published: (2005-12-01)

Ispol'zovanie inkretinov v lecheniisakharnogo diabeta 2 tipa - vcherashnyaya mechta,blizkaya k real'nosti segodnya
by: Ashot Musaelovich Mkrtumyan, et al.
Published: (2006-06-01)

Molekulyarno-geneticheskie osobennosti, kharakter metabolizma glyukozy i funktsiya endoteliya u bol'nykh metabolicheskim sindromom russkoy populyatsii
by: Ashot Musaelovich Mkrtumyan, et al.
Published: (2008-12-01)

Pathogenesis, clinical manifestations and treatment approaches for diabetic polyneuropathy
by: L. V. Nedosugova
Published: (2013-12-01)

The normative aspect of the Russian standard language in the methodology of Russian teaching as a foreign language
by: A B Nedosugova
Published: (2013-12-01)

EVALUATION OF THE EFFICIENCY OF ANTIRESORPTIVE THERAPY FOR OSTEOPOROSIS IN MULTIPAROUS WOMEN
by: I.G. MUKHAMEDOVA, et al.
Published: (2019-06-01)

Molecular Pharmacology of Antiresorptive Therapy for Osteoporosis
by: Adebanjo, O, et al.
Published: (1998)

The problem of low adherence to antiresorptive therapy with bisphosphonates: solutions
by: O. V. Yakushevskaya
Published: (2022-01-01)

Sulfonylureas in the modern strategy of therapy of type 2 diabetes
by: Lyudmila Viktorovna Nedosugova
Published: (2011-06-01)

The biological mechanisms of the antiresorptive therapy of osteoporosis, and the antiresorptive drug related osteonecrosis of jaws
by: István Gera, et al.
Published: (2024-03-01)

Obesity: a contemporary world issue. An overview of possible therapeutic approaches to therapy
by: A. M. Mkrtumyan
Published: (2018-03-01)

The influence of the running preparation on the aerobic and anaerobic threshold in ayear ́s training cycle at the cross triathlet
by: Svetlana Lipárová, et al.
Published: (2016-09-01)

Hypoglycemic therapy in patients with type 2 diabetes and chronic heart failure
by: S. V Kakorin, et al.
Published: (2014-03-01)

Factors of vascular calcification in patients with type 2 diabetes mellitus on long-term dialysis
by: Tatyana V. Archakova, et al.
Published: (2020-06-01)

Nonâinvasive ventilation in complex obstructive sleep apnea â A 15âyear experience of a pediatric tertiary center
by: I.C. Girbal, et al.
Published: (2014-05-01)

The Concept «Strength of Mind» in the Russian and Japanese Fraseology
by: A B Nedosugova
Published: (2014-12-01)

Some Aspects of Listening in Professional Language Training
by: A B Nedosugova
Published: (2012-06-01)

The teaching scientific style of in the methodology of Russian teaching as foreign language: the language education aspect
by: A B Nedosugova
Published: (2014-12-01)

The pragmatic approach to a formation of the Russian language personality in a new sociocultural reality
by: A B Nedosugova
Published: (2016-12-01)

The low and disproportionate utilization of antiresorptive therapy in patients with osseous metastasis
by: Amil R. Agarwal, et al.
Published: (2023-12-01)

BEST METHOD TO PREVENT COMPLICATIONS OF DIABETES MELLITUS IS TO ACHIEVE TARGET GLYCAEMIA VALUES
by: A. M. Mkrtumyan, et al.
Published: (2017-11-01)

Rannyaya peroral'naya sakharosnizhayushchaya terapiya pri sakharnom diabete tipa 2
by: Lyudmila Viktorovna Nedosugova
Published: (2002-09-01)

Vozmozhnye mekhanizmyantiateroskleroticheskogo effektaGlyukofazha (Metformina)
by: Lyudmila Viktorovna Nedosugova
Published: (2006-09-01)

Farmakoekonomicheskie aspekty lecheniya sakharnogo diabeta 2 tipa
by: Lyudmila Viktorovna Nedosugova
Published: (2008-06-01)

Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
by: Lyudmila Viktorovna Nedosugova
Published: (2013-06-01)

Glibenclamide - profile of efficacy and safety
by: Lyudmila Viktorovna Nedosugova
Published: (2011-09-01)

Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)
by: Sergey V. Kakorin, et al.
Published: (2016-07-01)

Medication burden of Saudi Arabian women receiving antiresorptive therapy
by: Sadat-Ali M, et al.
Published: (2012-08-01)

Management of the balanced development of the enterprises of oil industry
by: V. V. Biryukova
Published: (2017-08-01)

Stability of developing oil companies of Russia
by: V. V. Biryukova
Published: (2017-08-01)

Metformin is the most recognized first choice drug for patients with type 2 diabetes mellitus
by: A. M. Mkrtumyan
Published: (2018-03-01)

Pochemu i kak sleduet osushchestvlyat' korrektsiyu massy tela zhenshchiny bez ushcherba ee reproduktivnoy sistemy?
by: A M Mkrtumyan
Published: (2004-08-01)

Nephrological aspects ofblood diseases
by: L S Biryukova, et al.
Published: (2003-06-01)

The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.
by: D Black, et al.
Published: (2011-04-01)

Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy
by: E. V. Biryukova, et al.
Published: (2021-01-01)